Hande Bio Source, Inc (HBS) was established in 2003. Since inception, it has supplied high purity Active Pharmaceutical Ingredients (API) to the pharmaceutical industry from established, FDA-approved cGMP facilities. HBS's key supplier and partner is Yunnan Hande Bio-Tech, Co. Ltd, a pioneer of Paclitaxel API development and manufacturing in China, and the first Chinese manufacturer to have obtained approval for Paclitaxel API manufacturing from the US FDA, European EQDM, and Chinese SFDA.
History of Excellence
HBS has been distributor and FDA agent of Yunnan Hande Bio-tech, Co. Ltd (Yunnan Hande) since 2003, and has immediate access to all parts of the supply chain, and we offer direct support from QA team throughout each sale and shipment.
Yunnan Hande first filed DMF with US FDA for natural paclitaxel in 1996 and is the oldest Chinese manufacturer with 10 years experience supplying USA market, and over 15 years experience in botanical R&D, taxane production and taxus cultivation.
Sustainable Supply – Hande supplies both semi-synthetic and natural Paclitaxel. Natural Pacliaxel is harvested from Yunnan Hande's plantation of 30 million yew trees with capacity of 100 KG, ensuring fast and consistent supply.
Extensive Support – Over the years we have established close relationships with the manufacturer as a customer support team. As FDA agent, HBS has immediate access to all parts of the supply chain, and offers direct immediate communications from manufacturer’s QA team throughout each sale and shipment.
Hande has been long time supplier of finished dosage pharmaceutical manufacturers in active sales. We are also supporting customers in new drug development. HBS APIs are currently used in phase I, II and III clinical trials.